Mental Health6 min read

Antidepressants and breastfeeding: what is actually safe (updated 2026)

Wondering if antidepressants are safe while breastfeeding? Compare SSRIs, infant exposure, and what doctors consider compatible in 2026.

OR Olga RJune 29, 20266 min read

Antidepressants and breastfeeding: what is actually safe (updated 2026)

Table of contents

Why this question paralyses mothers SSRI safety comparison during breastfeeding Beyond SSRIs: other medication classes The risks of not treating What to ask your prescriber The LactMed database: your most reliable resource When to consider therapy instead of, or alongside, medication Key takeaways

Key takeaways

1Most antidepressants are compatible with breastfeeding, especially well-studied SSRIs like sertraline and paroxetine.
2Sertraline and paroxetine usually reach undetectable levels in baby’s blood at standard doses.
3Untreated postpartum depression can harm both mother and baby more than medication.
4Avoid stopping or starting antidepressants on your own; decide with your doctor.
5Accurate information matters because fear often leads mothers to skip effective treatment.

You are sitting in the GP's office, baby on your chest, prescription in your hand, asking the question that keeps millions of mothers awake: "Can I take this and still breastfeed?"

The doctor said yes. Your mother said she would not risk it. Google gave you three different answers before breakfast. And now you are holding an unopened box of sertraline in your kitchen drawer, doing nothing, because doing nothing feels safer than getting it wrong.

Antidepressants and breastfeeding are compatible in most cases. The most widely studied SSRIs, sertraline and paroxetine, reach mostly undetectable levels in infant blood. No controlled study has shown clinically significant adverse effects in breastfed infants exposed to these medications at standard doses. Untreated postpartum depression, by contrast, carries measurable risks for both mother and child, including impaired bonding, delayed infant development and increased maternal suicide risk.

This article compares the safety evidence for each medication class so you can make an informed decision with your doctor not instead of one.

Why this question paralyses mothers

A 2024 review published in PMC found that despite the prevalence of depression in lactating mothers, there is a lack of knowledge about the excretion of antidepressants into breast milk. This knowledge gap makes depressed breastfeeding mothers more likely to avoid pharmacological treatment entirely.

The result is a lose-lose: untreated depression harms the mother and the baby. Unnecessary medication avoidance harms the mother and deprives her of effective treatment. The only way out is accurate information.

SSRI safety comparison during breastfeeding

A 2024 pharmacokinetic study published in Frontiers in Pharmacology measured plasma and breastmilk concentrations of sertraline, citalopram and paroxetine in 37 mother-infant pairs. The findings:

Medication	Milk-to-plasma ratio	Infant exposure	Detectable in infant blood?	Recommendation
Sertraline	Low (0.42 to 4.81 range)	Infants had only 2% of maternal plasma levels on average	Mostly undetectable	Preferred choice during breastfeeding
Paroxetine	Low	Very low absolute infant dose	Mostly undetectable	Preferred choice during breastfeeding
Citalopram	Moderate	Higher than sertraline/paroxetine but still below clinical concern thresholds	Sometimes detectable at low levels	Acceptable; sertraline or paroxetine preferred if switching is possible
Escitalopram	Similar to citalopram	Low to moderate	Sometimes detectable	Acceptable; widely prescribed with good safety profile
Fluoxetine	Higher (longer half-life)	Higher infant exposure, especially if started during pregnancy	More frequently detectable	Use with caution; discuss timing and dose with prescriber

The study concluded that breastfeeding while taking sertraline, citalopram or paroxetine is safe, with sertraline and paroxetine as the preferred choices.

LactMed, the NIH's drug and lactation database (updated April 2026), maintains individual monographs for each SSRI with the most current evidence. For sertraline specifically, a 2025 study published in JAMA Network Open examined cognitive outcomes of children exposed to SSRIs through breast milk and found no adverse effects on child cognitive development.

"Given the well-known benefits of breastfeeding, our findings support that breastfeeding of infants by mothers who are taking sertraline, citalopram or paroxetine is safe." - Den Besten-Bertholee et al. (2024), Frontiers in Pharmacology

Beyond SSRIs: other medication classes

Medication class	Examples	Breastfeeding safety	Notes
SNRIs	Venlafaxine, duloxetine, desvenlafaxine	Generally compatible	Venlafaxine has more data; duloxetine has low milk transfer
Zuranolone	Zurzuvae (FDA-approved 2023)	Not recommended during breastfeeding	Limited lactation data; short 14-day course may allow pump-and-dump strategy; discuss with doctor
Tricyclics	Nortriptyline, amitriptyline	Compatible with caution	Older class; nortriptyline has best lactation data among tricyclics
Benzodiazepines	Lorazepam, clonazepam	Short-term use only	Sedation risk in infant; use lowest effective dose for shortest duration
Brexanolone	Zulresso (IV infusion)	Pump and discard during treatment	Administered in hospital; breastfeeding can resume after clearance

For a full comparison of medication vs therapy approaches to PPD, our CBT vs meds decision guide covers the evidence for both. And our comprehensive medication guide for PPD explains how SSRIs work, how long treatment lasts and what side effects to expect.

The risks of not treating

The conversation about antidepressants and breastfeeding almost always focuses on medication risk. It rarely discusses the risk of untreated depression.

Research consistently shows that untreated PPD is associated with:

Impaired mother-infant bonding and attachment
Delayed cognitive and language development in the infant
Increased risk of the child developing behavioural and emotional problems
Higher rates of breastfeeding cessation (depressed mothers are more likely to stop breastfeeding early)
Maternal suicide, which remains a leading cause of maternal death in the first postpartum year

A personalised risk-benefit analysis, conducted with your doctor, should weigh the known risks of untreated depression against the low and well-documented risks of SSRI exposure through breast milk. For most mothers, the balance favours treatment.

What to ask your prescriber

Before starting or continuing medication while breastfeeding, ask these questions:

Which SSRI has the best safety data during breastfeeding? (Sertraline and paroxetine have the most evidence)
What is the lowest effective dose for my symptoms?
Should I time doses to reduce peak breastmilk concentration? (Some prescribers recommend taking medication immediately after a feed)
How will you monitor my baby for any side effects?
When should I expect the medication to start working? (Typically 2 to 4 weeks for SSRIs)
How long should I stay on treatment? (Most guidelines recommend 6 to 12 months minimum after remission)

If your prescriber is unfamiliar with perinatal prescribing, ask for a referral to a perinatal psychiatrist. Our guide to choosing the right provider explains when a psychiatrist is the right choice.

The LactMed database: your most reliable resource

LactMed (lactmed.nlm.nih.gov) is maintained by the National Institutes of Health and updated regularly. It contains individual drug monographs with the latest research on breast milk transfer, infant exposure and reported side effects. It is free, evidence-based and more reliable than any forum, Facebook group or well-meaning relative.

If you want to check a specific medication, search it there before making any decisions.

When to consider therapy instead of, or alongside, medication

Therapy alone may be sufficient for mild to moderate PPD. Our CBT for postpartum depression guide covers the evidence for different formats, including online and telephone-delivered CBT. For moderate to severe symptoms, the combination of therapy and medication produces the best outcomes.

If you are still weighing whether to seek treatment at all, our article on why every new mom should consider therapy makes the case for acting before symptoms escalate. And our EPDS guide can help you understand your screening results before your next appointment.

Key takeaways

Sertraline and paroxetine are the preferred antidepressants during breastfeeding, with infant blood levels mostly undetectable in clinical studies.
Untreated postpartum depression carries greater risks to mother and child than SSRI exposure through breast milk at standard doses.
A 2025 JAMA study found no adverse cognitive effects in children exposed to SSRIs through breastfeeding.
LactMed (NIH) is the most reliable, free resource for checking individual medication safety during lactation.
The decision belongs to you and your doctor. No article, no relative and no online forum should replace a personalised clinical conversation.

Sources and further reading

Den Besten-Bertholee, D. et al. (2024). Sertraline, citalopram and paroxetine in lactation: passage into breastmilk and infant exposure. Frontiers in Pharmacology. pmc.ncbi.nlm.nih.gov
PMC. (2024). Assessment of infant exposure to antidepressants through breastfeeding: a literature review. pmc.ncbi.nlm.nih.gov
Heinonen, E.W. et al. (2025). Cognitive outcomes of children exposed to SSRIs through breast milk. JAMA Network Open. Cited in LactMed.
LactMed / NIH. (2026). Sertraline drug monograph. ncbi.nlm.nih.gov/books/NBK501191
Gentile, S. (2005). Antidepressant use during breastfeeding: a review of the evidence. Cited in PMC. pmc.ncbi.nlm.nih.gov
CANMAT. (2024). Clinical practice guideline for perinatal mood and anxiety disorders. Canadian Journal of Psychiatry.
Postpartum Support International: postpartum.net

Frequently asked questions

Is it safe to take antidepressants while breastfeeding?

In many cases, yes. The most studied antidepressants, especially sertraline and paroxetine, are generally considered compatible with breastfeeding because only very small amounts reach the baby.

Which antidepressants are usually preferred for breastfeeding mothers?

Sertraline is often the first choice, and paroxetine is another commonly preferred option. Both have low levels in breast milk and are usually undetectable or very low in infant blood at standard doses.

Do antidepressants pass into breast milk?

Yes, some amount can pass into breast milk, but the amount varies by medication. For the commonly recommended SSRIs, the exposure is usually low enough that clinically significant effects in the baby are not expected.

Can untreated postpartum depression affect my baby?

Yes. Untreated postpartum depression can affect bonding, daily care, and a baby’s emotional and developmental well-being. It can also increase serious risks for the mother, including worsening depression and suicide risk.

Should I stop breastfeeding if I need an antidepressant?

Not usually. In most cases, breastfeeding can continue while you take the right antidepressant, but the choice of medication and dose should be decided with your doctor based on your symptoms and medical history.

Back to Mental Health

Olga R

a freelance writer and certified maternal wellness coach with a background in psychology and over two years of experience writing about motherhood, mental health, and relationships.

View profile